OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer
Hongda Pan, Jingxin Pan, Pei Li, et al.
Clinical Immunology (2022) Vol. 238, pp. 109019-109019
Closed Access | Times Cited: 98
Hongda Pan, Jingxin Pan, Pei Li, et al.
Clinical Immunology (2022) Vol. 238, pp. 109019-109019
Closed Access | Times Cited: 98
Showing 1-25 of 98 citing articles:
Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 91
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 91
PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis
Chunxia Shi, Pan Cao, Yukun Wang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1523-1532
Open Access | Times Cited: 68
Chunxia Shi, Pan Cao, Yukun Wang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1523-1532
Open Access | Times Cited: 68
Xu Sun, Yanpeng Yang, Xiaona Meng, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 246-262
Open Access | Times Cited: 52
Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology
Zhe Wang, Yang Liu, Xing Niu
Seminars in Cancer Biology (2023) Vol. 93, pp. 83-96
Closed Access | Times Cited: 41
Zhe Wang, Yang Liu, Xing Niu
Seminars in Cancer Biology (2023) Vol. 93, pp. 83-96
Closed Access | Times Cited: 41
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment
Jie Gao, Anying Xiong, Jiliu Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 7, pp. 970-983
Open Access | Times Cited: 28
Jie Gao, Anying Xiong, Jiliu Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 7, pp. 970-983
Open Access | Times Cited: 28
Different types of cell death in diabetic endothelial dysfunction
Jieru Shen, Wenqing San, Yangyang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115802-115802
Open Access | Times Cited: 33
Jieru Shen, Wenqing San, Yangyang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115802-115802
Open Access | Times Cited: 33
Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 33
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 33
Current evidence and therapeutic implication of PANoptosis in cancer
Dickson Kofi Wiredu Ocansey, Fei Qian, Peipei Cai, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 640-661
Open Access | Times Cited: 27
Dickson Kofi Wiredu Ocansey, Fei Qian, Peipei Cai, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 640-661
Open Access | Times Cited: 27
PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma
Fei Song, Chenggui Wang, Jiazhen Mao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Fei Song, Chenggui Wang, Jiazhen Mao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
The emerging role of PANoptosis in cancer treatment
Yongai Xiong
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115696-115696
Open Access | Times Cited: 23
Yongai Xiong
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115696-115696
Open Access | Times Cited: 23
Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 10
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 10
Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients
Wei Zhang, Ruiyue Dang, Hongyi Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Wei Zhang, Ruiyue Dang, Hongyi Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Identification and verification of a PANoptosis-related long noncoding ribonucleic acid signature for predicting the clinical outcomes and immune landscape in lung adenocarcinoma
Lingling Bao, Yingquan Ye, Xuede Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29869-e29869
Open Access | Times Cited: 7
Lingling Bao, Yingquan Ye, Xuede Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29869-e29869
Open Access | Times Cited: 7
Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology
Raghvendra Mall, Ratnakar R. Bynigeri, Rajendra Karki, et al.
NAR Cancer (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 33
Raghvendra Mall, Ratnakar R. Bynigeri, Rajendra Karki, et al.
NAR Cancer (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 33
Comprehensive analysis illustrating the role of PANoptosis-related genes in lung cancer based on bioinformatic algorithms and experiments
Shiyou Wei, Zhigang Chen, Xinyu Ling, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Shiyou Wei, Zhigang Chen, Xinyu Ling, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer
Biao Zhang, Bingqian Huang, Xiaonan Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Biao Zhang, Bingqian Huang, Xiaonan Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Molecular characterization of PANoptosis-related genes with features of immune dysregulation in systemic lupus erythematosus
Wei Sun, Pengchong Li, Min Wang, et al.
Clinical Immunology (2023) Vol. 253, pp. 109660-109660
Closed Access | Times Cited: 18
Wei Sun, Pengchong Li, Min Wang, et al.
Clinical Immunology (2023) Vol. 253, pp. 109660-109660
Closed Access | Times Cited: 18
PANoptosis signaling enables broad immune response in psoriasis: From pathogenesis to new therapeutic strategies
Xi‐min Hu, Shengyuan Zheng, Qí Zhāng, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 23, pp. 64-76
Open Access | Times Cited: 18
Xi‐min Hu, Shengyuan Zheng, Qí Zhāng, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 23, pp. 64-76
Open Access | Times Cited: 18
PANoptosis: Emerging mechanisms and disease implications
Zehong Qi, Lili Zhu, Kangkai Wang, et al.
Life Sciences (2023) Vol. 333, pp. 122158-122158
Closed Access | Times Cited: 16
Zehong Qi, Lili Zhu, Kangkai Wang, et al.
Life Sciences (2023) Vol. 333, pp. 122158-122158
Closed Access | Times Cited: 16
Development and experimental validation of a machine learning-based disulfidptosis-related ferroptosis score for hepatocellular carcinoma
Cong Zhang, Tiantian Xu, Kun Ji, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 103-120
Closed Access | Times Cited: 16
Cong Zhang, Tiantian Xu, Kun Ji, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 103-120
Closed Access | Times Cited: 16
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma
Xinrui Shi, Xia Gao, W. Liu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 569-590
Open Access | Times Cited: 15
Xinrui Shi, Xia Gao, W. Liu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 569-590
Open Access | Times Cited: 15
Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma
Zhansheng Jiang, Jiahe Wang, Chenghuan Dao, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 681-692
Closed Access | Times Cited: 6
Zhansheng Jiang, Jiahe Wang, Chenghuan Dao, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 681-692
Closed Access | Times Cited: 6
Ultrasmall Enzyodynamic PANoptosis Nano‐Inducers for Ultrasound‐Amplified Hepatocellular Carcinoma Therapy and Lung Metastasis Inhibition
Wuyang Wei, Hai Wang, Ren Chunrong, et al.
Advanced Materials (2024) Vol. 36, Iss. 45
Closed Access | Times Cited: 6
Wuyang Wei, Hai Wang, Ren Chunrong, et al.
Advanced Materials (2024) Vol. 36, Iss. 45
Closed Access | Times Cited: 6
Inflammatory cell death PANoptosis is induced by the anti-cancer curaxin CBL0137 via eliciting the assembly of ZBP1-associated PANoptosome
Yaping Li, Zhi-ya Zhou, Yan Liang, et al.
Inflammation Research (2024) Vol. 73, Iss. 4, pp. 597-617
Closed Access | Times Cited: 5
Yaping Li, Zhi-ya Zhou, Yan Liang, et al.
Inflammation Research (2024) Vol. 73, Iss. 4, pp. 597-617
Closed Access | Times Cited: 5
A PANoptosis pattern to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma
Feng Gao, Minghuan Zhang, Zhenguang Ying, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27162-e27162
Open Access | Times Cited: 5
Feng Gao, Minghuan Zhang, Zhenguang Ying, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27162-e27162
Open Access | Times Cited: 5
